Submitted by: Submitted by ambikabasa
Views: 10
Words: 583
Pages: 3
Category: Business and Industry
Date Submitted: 07/09/2015 03:29 AM
ResearchMoz.us include new market research report"Partnerships, Licensing, Investments and M&A Deals and Trends for April 2015 in Pharmaceuticals" to its huge collection of research reports.
Partnerships, Licensing, Investments and M&A Deals and Trends for April 2015 in Pharmaceuticals
Summary
GlobalData's Partnerships, Licensing, Investments and M&A Deals and Trends for April 2015 in Pharmaceuticals report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the pharmaceuticals industry in April 2015.
Complete Report @ http://www.researchmoz.us/partnerships-licensing-investments-and-manda-deals-and-trends-for-april-2015-in-pharmaceuticals-report.html
The report portrays detailed comparative data on the number of deals and their value in the last six months, subdivided by deal types, various therapy areas, and geographies. Additionally, the report provides information on the top financial advisory firms in the pharmaceuticals industry.
Data presented in this report is derived from GlobalDatas proprietary in-house Pharmaceuticals eTrack deals database and primary and secondary research.
Scope
- Analysis of the market trends for the pharmaceutical industry in the global arena.
- Review of deal trends in the cardiovascular, central nervous system, dermatology, ear nose throat disorders, gastrointestinal, genito urinary system and sex hormones, hematological disorders, hormonal disorders, immunology, infectious disease, male health, metabolic disorders, mouth and dental disorders, musculoskeletal, oncology, ophthalmology, respiratory, toxicology, and women's health segments.
- Analysis of partnerships, licensing, M&As, equity/debt offerings, private equity, and venture financing...